Special Issue "Smoking Cessation after a Cancer Diagnosis"
A special issue of Current Oncology (ISSN 1718-7729).
Deadline for manuscript submissions: closed (15 February 2022) | Viewed by 13876
Interests: smoking cessation; cost and cost-effectiveness; real-world evidence
Interests: smoking cessation; health professions education; health equity
Achieving the best outcomes for cancer patients requires the delivery of sophisticated surgery, high-precision radiotherapy and an ever-expanding variety of systemic therapies often administered in combination. However, for each of these therapies to achieve their maximum benefit with the least possible toxicity, cancer patients who smoke will need help in quitting. Furthermore, advances in these therapies have led to a growing population of cancer survivors, including patients with metastatic disease, who would derive many non-cancer-related (e.g., cardiorespiratory) benefits if they quit smoking. There is still much to be learned about the interactions between tobacco smoke and the cancer therapies used by oncologists, particularly systemic therapies. This Special Issue will focus on what is currently known about the impact of smoking on each of the key cancer treatment modalities and underscore the need for more research on how continued smoking impacts the effectiveness of the different classes of new agents. Practical advice on how to help cancer patients quit and lessons learned by institutions and health systems that have tried to implement smoking cessation initiatives will provide guidance to health care providers seeking to deliver high-quality cancer care to their patients.
Prof. emer. William K. Evans
Dr. Meredith Giuliani
Dr. Lawson Eng
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- smoking cessation
- radiation therapy
- systemic therapy
- quality care
- implementing smoking cessation